Integrated Biopharma INBP Balance Sheet (2010-2026)

OTC INBP
$0.17 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST
Reported Financials

Integrated Biopharma Quarterly Balance Sheet

Periods 65 quarters
Latest Sep 2026

Integrated Biopharma reported total assets of $24.03M and total liabilities of $7.01M for the quarter ended Sep 2026, down 5.9% year over year. This balance sheet covers 65 quarters of results from Sep 2010 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
0.16M0.26M0.33M1.17M1.09M2.53M1.32M2.59M0.73M2.02M1.68M2.27M2.46M2.96M3.62M4.73M5.31M5.83M4.47M3.12M
Cash & Current Investments
0.16M0.26M0.33M1.17M1.09M2.53M1.32M2.59M0.73M2.02M1.68M2.27M2.46M2.96M3.62M4.73M5.31M5.83M4.47M3.12M
Receivables - NetNet Receivables
5.47M6.17M4.89M3.71M4.51M4.68M4.51M4.17M3.73M4.72M4.67M4.39M4.23M5.08M5.43M3.98M3.59M3.66M3.33M3.72M
Receivables
5.47M6.17M4.89M3.71M4.51M4.68M4.51M4.17M3.73M4.72M4.67M4.39M4.23M5.08M5.43M3.98M3.59M3.66M3.33M3.72M
Raw Materials
10.25M9.77M7.59M9.06M7.76M7.64M6.86M8.42M9.89M8.51M7.89M8.70M8.28M6.42M5.73M7.21M5.64M6.06M6.10M
Work In Process
1.73M2.14M1.76M1.50M1.46M1.45M2.15M1.15M1.64M1.82M2.45M1.53M1.69M2.34M2.74M1.58M1.32M1.09M1.90M
Finished Goods
1.13M1.19M1.44M1.12M1.04M0.85M1.25M0.95M0.62M0.84M0.91M0.99M1.10M1.32M0.90M1.69M1.40M0.97M1.14M
Inventory
13.12M13.10M11.06M11.67M10.26M9.94M10.26M10.51M12.15M11.17M11.24M11.22M11.07M10.08M9.36M10.47M8.36M8.12M9.14M8.55M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
0.60M0.51M0.35M0.52M0.53M0.36M0.28M0.48M0.45M0.35M0.29M0.43M0.40M0.43M0.36M0.44M0.55M0.37M0.43M0.60M
Current Assets
19.35M20.04M16.63M17.06M16.39M17.51M16.37M17.76M17.07M18.26M17.88M18.31M18.15M18.55M18.76M19.62M17.82M17.97M17.38M15.98M
Non-Current Assets
Land & Improvements
Property, Plant & Equipment (Net)PP&E (Net)
1.80M1.94M1.91M1.85M1.79M1.72M1.65M1.64M1.56M1.89M1.80M1.85M1.77M1.81M1.72M1.82M1.77M1.70M1.75M1.81M
Intangibles
Goodwill & Intangibles
Long-Term Deferred Tax
3.75M3.67M4.80M4.76M4.76M4.76M4.73M4.72M4.79M4.71M4.60M4.40M4.35M4.11M3.34M3.27M3.39M3.59M3.08M3.32M
Other Non-Current Assets
0.06M0.05M0.05M0.04M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.05M0.05M0.05M0.05M0.05M0.05M0.16M
Non-Current Assets
7.72M7.65M8.62M9.30M9.67M9.37M9.84M8.88M8.66M8.68M8.33M7.87M7.51M7.11M6.14M5.92M5.73M8.70M7.96M8.05M
Assets
27.07M27.70M25.25M26.36M26.05M26.88M26.21M26.64M25.72M26.94M26.21M26.18M25.66M25.66M24.90M25.54M23.55M26.67M25.34M24.03M
Liabilities
Current Liabilities
Accounts Payables
4.24M4.69M3.21M3.53M2.96M3.53M2.27M3.54M3.31M3.67M2.51M2.76M2.81M2.50M2.27M2.80M2.14M2.97M3.20M2.82M
Notes Payables
Payables
4.24M4.69M3.21M3.53M2.96M3.53M2.27M3.54M3.31M3.67M2.51M2.76M2.81M2.50M2.27M2.80M2.14M2.97M3.20M2.82M
Accumulated Expenses
1.48M1.31M1.41M1.49M1.32M1.71M1.63M1.71M1.58M2.32M2.66M2.31M1.80M1.64M1.30M1.49M1.13M1.38M1.39M1.41M
Other Accumulated Expenses
3.00M
Short term Debt
3.16M2.73M0.13M0.04M0.04M0.04M0.04M0.02M0.01M
Current Leases
0.50M0.51M0.76M0.87M0.88M0.04M0.04M0.03M0.01M0.01M0.05M0.05M0.05M0.05M0.05M0.05M
Total Current Liabilities
9.38M9.23M5.26M5.81M5.19M6.16M4.83M6.20M5.83M6.95M6.12M6.03M5.58M4.98M4.25M4.76M3.54M5.53M5.80M5.45M
Non-Current Liabilities
Capital Leases
0.09M0.01M0.03M0.12M0.10M0.09M0.07M0.07M0.06M
Non-Current Debt
0.05M0.04M0.03M0.02M0.01M
Convertible Debt
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
Operating Leases
1.62M1.49M1.36M1.89M2.18M1.96M1.74M1.56M1.32M1.09M0.85M0.60M0.36M0.26M0.22M0.18M0.15M2.08M1.80M1.50M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities
11.00M10.72M6.68M7.74M7.40M26.86M7.35M7.76M7.16M8.03M6.97M7.63M25.64M5.27M4.58M5.05M3.78M7.69M7.67M7.01M
Shareholder's Equity
Total Debt
3.16M2.73M0.19M0.08M0.07M0.06M0.05M0.02M0.01M
Common Equity
16.07M16.98M18.58M18.62M18.65M0.02M18.86M18.89M18.57M18.91M19.24M18.55M0.02M20.38M20.32M20.49M19.77M18.98M17.67M17.02M
Liabilities and Shareholders Equity
27.07M27.70M25.25M26.36M26.05M26.88M26.21M26.64M25.72M26.94M26.21M26.18M25.66M25.66M24.90M25.54M23.55M26.67M25.34M24.03M
Treasury Stock
0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M-0.10M
Retained Earnings
-34.60M-33.80M-32.31M-32.34M-32.40M-32.38M-32.34M-32.40M-32.78M-32.50M-32.23M-31.97M-31.85M-31.24M-31.42M-31.30M-32.06M-32.90M-34.26M-34.95M
Preferred Shares
Treasury Shares
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M

Integrated Biopharma Balance Sheet API

Pull Integrated Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INBP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY